Quantcast
Channel: Don't trade our lives away » Imatinib
Browsing latest articles
Browse All 10 View Live

Image may be NSFW.
Clik here to view.

The Roadmap: The HIV Drug Pipeline and its Patents

Source:I-MAK 11th April,2013 The implications of last week’s Indian Supreme Court decision upholding the efficacy standard for drug patents are unmistakable.    Simply put, the decision can and should...

View Article



Image may be NSFW.
Clik here to view.

‘Novartis case: Supreme Court ruling wise and balanced’

Source: Rediff April 10,2013 The Supreme Court recently rejected the plea of Novartis [ Get Quote ] AG for patent protection of its anti-cancer drug Glivec. The Supreme Court  judgement (pages 22 -26)...

View Article

Image may be NSFW.
Clik here to view.

Why are our medicines so expensive?

Source:euobserver BY ELS TORREELE BRUSSELS - In the lead-up to an inter ministerial meeting between EU and India next week, European trade negotiators continue to pressure India and other developing...

View Article

Image may be NSFW.
Clik here to view.

The Larger Implications of the Novartis-Glivec Judgment

Source: Economic and Political Weekly Vol XLVIII No.17 by Sudip Chaudhari April 27,2013 The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific...

View Article

Image may be NSFW.
Clik here to view.

South Africa seeks to close drug patent loophole

Source: Healthnexercise April 23, 2013 By Wendell Roelf CAPE TOWN (Reuters) – South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder...

View Article


Image may be NSFW.
Clik here to view.

Doctors Denounce Cancer Drug Prices of $100,000 a Year

Source: New York Times  April 25,2013 With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual...

View Article

Image may be NSFW.
Clik here to view.

5 Take-Home Points From India’s Historic Novartis Patent Case

 Source: Asian Scientist Apr. 29, 2013– On April 1, 2013, the Indian Supreme Court dismissed the attempt by Novartis, a Swiss pharmaceutical company, to obtain patent protection for a new version of...

View Article

Image may be NSFW.
Clik here to view.

The real cancer killer: rip-off prices for drugs set by ‘profiteering’ Big...

Source: The Independent April 29,2013 An influential group of cancer experts has warned that the high prices charged by pharmaceutical companies for cancer drugs are effectively condemning patients to...

View Article


Image may be NSFW.
Clik here to view.

WTO unimpressed with patent violation charges against India

Source: Hindu Business Line 26th April No country has objected to India issuing compulsory licence or refusing patent for drugs: WTO chief Pascal Lamy GENEVA: Global pharma majors are unlikely to get...

View Article


Image may be NSFW.
Clik here to view.

A victory for global public health in the Indian, Ellen T Hoen

Source: Journal of Public Health Policy Abstract On 1 April of this year, the Indian Supreme Court upheld the decision of the Indian Patent Office to refuse the patent grant for Novartis imatinib...

View Article
Browsing latest articles
Browse All 10 View Live


Latest Images